66616-52-2

4-[(5-phenoxyfuran-2-yl)methyl]morpholine hydrochloride

2-Pyridinecarboxaldehyde, 6-methyl-4-(trifluoromethyl)-,O-[(2-methoxy-6-methylphenyl)methyl]oxime

2-Pyridinecarbonitrile,6-[1-[(3-methylimidazo[1,2-a]pyrimidin-2-yl)methyl]-1H-imidazol-2-yl]-

Butanamide, N-(3,5-dichlorophenyl)-2-(formylmethylamino)-3-methyl-,(2S)-

2-Naphthalenecarboxylic acid,6-[[[(1,1-dimethylethoxy)carbonyl]amino]methyl]-5,6,7,8-tetrahydro-,methyl ester

2-Pyridinecarboxaldehyde, 1,6-dihydro-1-methyl-6-oxo-, 2-oxime, (E)-

2H-Pyran-4-propanoic acid,6-(ethoxycarbonyl)-2-oxo-a-[(trifluoroacetyl)amino]-, ethyl ester

2-Pyridinecarboxamide, N-(2,3-dihydro-1H-inden-2-yl)-

2-Pyridinecarboxamide, N-ethyl-5-[[(4-fluorophenyl)methyl]amino]-

2-Naphthalenecarboxylic acid,(2E)-[3-(3-fluorophenyl)-2-methyl-2-propenylidene]hydrazide

2-Pyridinecarboxamide, 4-(3-aminophenoxy)-

2H-Pyran-6-carboxamide,N-cyclohexyl-2-ethoxy-3,4-dihydro-3-[2-[2-(2-hydroxyethoxy)ethoxy]ethyl]-N-methyl-4-(1-methylethyl)-, (2R,3R,4S)-

2-Naphthalenecarboxylic acid,(1S)-1-[(4S)-2-(3-chlorophenyl)-3-[(4-methylphenyl)sulfonyl]-5-oxo-1,3,2-oxazaborolidin-4-yl]ethyl ester

Carbamic acid,[6-amino-4-[[(1S,2R)-2-hydroxy-1-methyl-2-phenylethyl]amino]-5-nitro-2-pyridinyl]-, ethyl ester

4-[7-(1-amino-ethyl)-6-ethyl-4,4-dimethyl-3,4-dihydro-2H-quinolin-1-ylmethyl]-pyridine-2-carbonitrile

Quinazoline, 4,4'-dithiobis[2-phenyl-

2H-Pyran-4-ol, 4-(3,5-dimethylphenyl)tetrahydro-

2H-Pyran-5-carboxamide,N-(3-methoxyphenyl)-4-(4-methoxyphenyl)-2-oxo-

1-[7-(1-amino-ethyl)-6-ethyl-4,4-dimethyl-3,4-dihydro-2H-quinolin-1-yl]-2-methoxy-ethanone

2-Naphthalenecarboxylic acid,5-chloro-1,2,3,4-tetrahydro-6,7-dimethoxy-

2-Pyridinecarboxamide, 4-(4-amino-3-nitrophenoxy)-N-methyl-

2H-Pyran-6-carboxylic acid,4-(3-fluorophenyl)-3,4-dihydro-3-(1-methylethyl)-2-(1-piperidinyl)-,methyl ester

2-Pyridinecarbothioamide, 5-chloro-

2-Pyridinecarbothioamide, N-(2-methylpropyl)-

Thiourea, N-methyl-N'-[4-(3-pyridinylmethyl)phenyl]-

2-Pyridinecarboxamide, N-ethoxy-

2-Pyridinecarboxamide, 4-(4-amino-2,3-difluorophenoxy)-

2-Pyridinecarboxaldehyde, 6-methyl-4-(trifluoromethyl)-,O-[(3,6-difluoro-2-methoxyphenyl)methyl]oxime

2-Naphthalenecarboxylic acid,1,2,3,4-tetrahydro-2-[(4-nitrophenyl)methyl]-1-oxo-, methyl ester, (2S)-

2-Pyridinecarboxaldehyde, 5-[(phenylsulfonyl)oxy]-

2-Naphthalenecarboxylic acid,1-hydroxy-6,8-dimethoxy-3-(methoxymethyl)-, methyl ester

2-Naphthalenecarboxylic acid,7-[[(2-chlorophenyl)amino]carbonyl]-6-hydroxy-

2-Pyridinecarboxaldehyde, 6-methyl-4-(trifluoromethyl)-, oxime

2H-Pyran-6-carboxylic acid, 4-(bromomethyl)-2-oxo-, methyl ester

2-Naphthalenecarboxylic acid,4-[[4-(acetylamino)-2-sulfophenyl]azo]-3-hydroxy-, strontium salt (1:1)

2,7-Naphthyridin-1(2H)-one, 5-broMo-

2-Pyridinecarboxamide, 3-hydroxy-4,5-bis(hydroxymethyl)-

66616-52-2 msds

CAS No 66616-52-2 supplier

CASNo 66616-52-2 distributor

CAS # 66616-52-2 manufacturer

CAS Number 66616-52-2 safety

CAS RN 66616-52-2 wholesale

2026-10-15 Find 4-[(5-phenoxyfuran-2-yl)methyl]morpholine hydrochloride,CAS No.66616-52-2,Formula:C15H18ClNO3 in 9CMX